The Chemours Company (CC) Financial Ratios
14 years of historical data (2012–2025) · Basic Materials · Chemicals - Specialty
EV/EBITDA
↑
21.43
↑+29% vs avg
5yr avg: 16.60
30Y Low5.2·High42.4
P/FCF
↑
64.07
↑+215% vs avg
5yr avg: 20.35
30Y Low7.6·High41.9
P/B Ratio
↑
13.06
↑+140% vs avg
5yr avg: 5.45
30Y Low4.2·High39.0
ROE
↓
-90.2%
↑-3383% vs avg
5yr avg: 2.7%
30Y Low-90%·High154%
Debt/EBITDA
↑
13.69
↑+35% vs avg
5yr avg: 10.11
30Y Low2.6·High23.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
CC Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
The Chemours Company currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 64.1x P/FCF, 215% above the 5-year average of 20.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3.3B | $1.8B | $2.5B | $4.7B | $4.8B | $5.7B | $4.1B | $3.0B | $5.2B | $9.6B | $4.1B |
| Enterprise Value | $7.2B | $5.7B | $6.2B | $7.8B | $7.6B | $8.2B | $7.3B | $6.5B | $7.9B | $12.1B | $6.7B |
| P/E Ratio → | -8.50 | — | 29.65 | — | 8.39 | 9.32 | 18.78 | — | 5.18 | 12.80 | 552.25 |
| P/S Ratio | 0.56 | 0.31 | 0.44 | 0.77 | 0.71 | 0.89 | 0.83 | 0.54 | 0.78 | 1.55 | 0.75 |
| P/B Ratio | 13.06 | 7.07 | 4.19 | 6.36 | 4.38 | 5.23 | 5.06 | 4.29 | 5.05 | 11.05 | 38.96 |
| P/FCF | 64.07 | 34.80 | — | 25.25 | 10.82 | 10.54 | 7.64 | 17.64 | 8.03 | 41.93 | 15.83 |
| P/OCF | 12.38 | 6.72 | — | 8.45 | 6.42 | 6.96 | 5.11 | 4.59 | 4.52 | 14.96 | 6.82 |
P/E links to full P/E history page with 30-year chart
CC EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
The Chemours Company's enterprise value stands at 21.4x EBITDA, 29% above its 5-year average of 16.6x. The Basic Materials sector median is 11.0x, placing the stock at a 95% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.98 | 1.07 | 1.28 | 1.12 | 1.29 | 1.47 | 1.18 | 1.19 | 1.96 | 1.24 |
| EV / EBITDA | 21.43 | 16.98 | 8.30 | 42.35 | 7.08 | 8.27 | 9.50 | 9.10 | 5.23 | 9.01 | 17.61 |
| EV / EBIT | — | — | 15.80 | — | 8.43 | 9.52 | 16.32 | 14.56 | 6.29 | 10.76 | 32.18 |
| EV / FCF | — | 111.53 | — | 41.90 | 17.02 | 15.27 | 13.51 | 38.52 | 12.34 | 53.14 | 26.15 |
CC Profitability
Margins and return-on-capital ratios measuring operating efficiency
The Chemours Company earns an operating margin of -0.1%, below the Basic Materials sector average of 10.3%. Operating margins have expanded from -2.0% to -0.1% over the past 3 years, signaling improving operational efficiency. A negative ROE of -90.2% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 15.5% | 15.5% | 19.9% | 21.5% | 23.7% | 21.8% | 21.5% | 19.2% | 29.7% | 28.4% | 20.6% |
| Operating Margin | -0.1% | -0.1% | 7.7% | -2.0% | 11.5% | 10.6% | 9.0% | 8.1% | 18.6% | 17.3% | 1.8% |
| Net Profit Margin | -6.6% | -6.6% | 1.5% | -3.9% | 8.5% | 9.6% | 4.4% | -0.9% | 15.0% | 12.1% | 0.1% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -90.2% | -90.2% | 12.8% | -25.8% | 52.8% | 64.1% | 29.0% | -6.1% | 105.6% | 154.0% | 6.0% |
| ROA | -5.2% | -5.2% | 1.1% | -3.0% | 7.6% | 8.3% | 3.1% | -0.7% | 13.6% | 11.2% | 0.1% |
| ROIC | -0.1% | -0.1% | 8.2% | -2.4% | 15.7% | 13.3% | 8.2% | 8.4% | 25.6% | 26.1% | 2.2% |
| ROCE | -0.1% | -0.1% | 7.7% | -2.1% | 13.7% | 11.9% | 7.9% | 7.9% | 21.8% | 21.6% | 2.1% |
CC Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The Chemours Company carries a Debt/EBITDA ratio of 13.7x, which is highly leveraged (463% above the sector average of 2.4x). Net debt stands at $3.9B ($4.6B total debt minus $672M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 18.27 | 18.27 | 7.20 | 5.82 | 3.50 | 3.68 | 5.25 | 6.43 | 3.89 | 4.75 | 34.08 |
| Debt / EBITDA | 13.69 | 13.69 | 5.85 | 23.36 | 3.60 | 4.02 | 5.57 | 6.25 | 2.62 | 3.06 | 9.33 |
| Net Debt / Equity | — | 15.59 | 6.02 | 4.19 | 2.51 | 2.34 | 3.89 | 5.08 | 2.72 | 2.95 | 25.40 |
| Net Debt / EBITDA | 11.68 | 11.68 | 4.90 | 16.83 | 2.58 | 2.56 | 4.13 | 4.93 | 1.83 | 1.90 | 6.95 |
| Debt / FCF | — | 76.73 | — | 16.65 | 6.20 | 4.72 | 5.87 | 20.88 | 4.32 | 11.21 | 10.32 |
| Interest Coverage | -0.03 | -0.03 | 1.48 | -0.53 | 5.55 | 4.65 | 2.13 | 2.15 | 6.46 | 5.24 | 0.95 |
CC Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.78x means The Chemours Company can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.85x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has improved from 1.54x to 1.78x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.78 | 1.78 | 1.68 | 1.54 | 1.70 | 1.80 | 1.83 | 1.80 | 1.93 | 2.12 | 1.44 |
| Quick Ratio | 0.85 | 0.85 | 0.86 | 1.00 | 0.96 | 1.21 | 1.17 | 1.10 | 1.26 | 1.55 | 1.01 |
| Cash Ratio | 0.40 | 0.40 | 0.40 | 0.48 | 0.58 | 0.78 | 0.77 | 0.61 | 0.70 | 0.94 | 0.51 |
| Asset Turnover | — | 0.79 | 0.77 | 0.74 | 0.89 | 0.84 | 0.70 | 0.76 | 0.90 | 0.85 | 0.89 |
| Inventory Turnover | 3.13 | 3.13 | 3.15 | 3.53 | 3.71 | 4.52 | 4.16 | 4.14 | 4.07 | 4.74 | 5.59 |
| Days Sales Outstanding | — | 42.67 | 48.61 | 36.63 | 33.45 | 41.42 | 37.54 | 44.52 | 47.34 | 54.25 | 54.55 |
CC Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
The Chemours Company returns 2.4% to shareholders annually primarily through dividends.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.4% | 4.4% | 5.8% | 3.2% | 3.2% | 2.9% | 4.0% | 5.5% | 2.9% | 0.2% | 0.5% |
| Payout Ratio | — | — | 172.1% | — | 26.6% | 27.0% | 74.9% | — | 14.9% | 2.9% | 314.3% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 3.4% | — | 11.9% | 10.7% | 5.3% | — | 19.3% | 7.8% | 0.2% |
| FCF Yield | 1.6% | 2.9% | — | 4.0% | 9.2% | 9.5% | 13.1% | 5.7% | 12.5% | 2.4% | 6.3% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 1.5% | 10.2% | 3.1% | 0.0% | 10.8% | 12.5% | 1.1% | 0.0% |
| Total Shareholder Yield | 2.4% | 4.4% | 5.8% | 4.6% | 13.4% | 6.0% | 4.0% | 16.3% | 15.4% | 1.3% | 0.5% |
| Shares Outstanding | — | $151M | $150M | $149M | $158M | $169M | $166M | $165M | $183M | $191M | $183M |
Peer Comparison
Compare CC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 CCYou | $3B | -8.5 | 21.4 | 64.1 | 15.5% | -0.1% | -90.2% | -0.1% | 13.7 |
 TROX | $1B | -2.5 | 16.2 | — | 9.3% | -0.7% | -29.0% | -0.3% | 12.8 |
 KRO | $787M | -7.1 | 58.0 | — | 11.5% | -2.3% | -14.1% | -2.5% | 25.2 |
 OLN | $3B | -59.5 | 9.0 | 10.1 | 7.4% | 1.7% | -2.1% | 1.7% | 5.3 |
 ASIX | $535M | 11.0 | 6.1 | 83.4 | 11.4% | 4.4% | 6.2% | 4.4% | 2.6 |
 HUN | $2B | -7.6 | 17.8 | 18.1 | 13.2% | -0.7% | -9.0% | -0.6% | 11.0 |
 EMN | $8B | 17.7 | 8.9 | 19.6 | 21.1% | 10.6% | 8.0% | 6.7% | 3.5 |
 CE | $6B | -4.8 | 11.5 | 7.1 | 18.8% | 8.0% | -23.1% | 3.4% | 8.6 |
 AVNT | $3B | 42.3 | 12.5 | 17.7 | 32.5% | 6.2% | 3.5% | 3.9% | 4.9 |
 RPM | $14B | 20.2 | 15.0 | 25.7 | 41.4% | 12.3% | 25.5% | 13.3% | 2.7 |
 FUL | $4B | 23.6 | 9.4 | 29.0 | 31.7% | 11.5% | 7.9% | 7.8% | 3.5 |
| Basic Materials Median | — | 23.6 | 11.0 | 29.0 | 30.9% | 10.3% | -0.0% | 4.6% | 2.4 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 14 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
CC — Frequently Asked Questions
Quick answers to the most common questions about buying CC stock.
What is The Chemours Company's P/E ratio?
The Chemours Company's current P/E ratio is -8.5x. The historical average is 14.0x.
What is The Chemours Company's EV/EBITDA?
The Chemours Company's current EV/EBITDA is 21.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.0x.
What is The Chemours Company's ROE?
The Chemours Company's return on equity (ROE) is -90.2%. The historical average is 25.3%.
Is CC stock overvalued?
Based on historical data, The Chemours Company is trading at a P/E of -8.5x. Compare with industry peers and growth rates for a complete picture.
What is The Chemours Company's dividend yield?
The Chemours Company's current dividend yield is 2.38%.
What are The Chemours Company's profit margins?
The Chemours Company has 15.5% gross margin and -0.1% operating margin.
How much debt does The Chemours Company have?
The Chemours Company's Debt/EBITDA ratio is 13.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.